Valuation: Star Scientific, Inc.

Market Cap 153K 137K 127K 115K 214K 14.57M 218K 1.51M 605K 7.66M 576K 563K 24.16M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.94M 16.51M 14.94M 27.96M 1.9B 28.46M 196M 78.91M 999M 75.09M 73.49M 3.15B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.19%+11.31%+67.86%+150.58% 1,263B
-0.73%+3.56%+44.51%+85.81% 658B
+1.41%+3.24%+29.22%+107.83% 521B
+0.42%+3.20%+54.15%+67.18% 391B
+2.18%+2.93%+73.30%+45.62% 369B
+1.12%+4.52%+35.30%+58.08% 307B
+6.96%+8.86%+11.27%+36.62% 290B
+1.15%+6.09%+59.59%+77.06% 252B
+3.06%+9.38%+44.11%+119.47% 212B
Average +2.08%+5.90%+46.59%+83.14% 473.55B
Weighted average by Cap. +2.01%+6.60%+50.88%+98.31%

Financials

2014 2015
Net sales - -
Net income -38.52M -34.52M -31.77M -28.76M -53.82M -3.66B -54.79M -378M -152M -1.92B -145M -141M -6.07B -6.84M -6.14M -5.65M -5.11M -9.56M -650M -9.74M -67.17M -26.99M -342M -25.69M -25.14M -1.08B
Net Debt -45K -40.33K -37.12K -33.6K -62.88K -4.27M -64.01K -442K -177K -2.25M -169K -165K -7.09M 19.86M 17.8M 16.38M 14.83M 27.75M 1.89B 28.25M 195M 78.3M 991M 74.52M 72.93M 3.13B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-